Kusuri No Aoki Holdings Co., Ltd.: history, ownership, mission, how it works & makes money

Kusuri No Aoki Holdings (TSE: 3549.T), founded in 1999, has grown from a single retailer of pharmaceuticals, cosmetics and daily goods into a nationwide network led by brothers Hironori and Takanori Aoki, combining rapid store expansion (multiple new dispensing pharmacies in January 2025) with strong top-line momentum-reported a 13.8% rise in net sales for the nine months to February 20, 2025 and a 68.6% jump in profits attributable to owners year‑over‑year, while a broader fiscal-year view showed a 14.8% increase in net sales to May 20, 2025; governance has come under scrutiny after a discounted stock option issue in 2020 led activist Oasis Management (holding 9.7% as of July 2024) to sue in July 2024, and the company has sought to boost liquidity and investor access through a 3-for-1 share split in November 2023, all against a backdrop of diversified revenue streams-from prescription dispensing to cosmetics, food, baby and pet categories-and a market capitalization of ¥357.66 billion as of December 12, 2025.

Kusuri No Aoki Holdings Co., Ltd. (3549.T): Intro

• Founded: 1999 (retail focus: pharmaceuticals, cosmetics, daily goods).
• Corporate actions: 3-for-1 share split in November 2023 to improve liquidity and broaden investor base.
• Governance controversy: stock options issued in 2020 to President Hironori Aoki and Vice President Takanori Aoki at discounted rates; in July 2024 activist investor Oasis Management filed a lawsuit alleging governance failures related to those grants.

• Retail sales: OTC medicines, cosmetics, daily goods (high-margin private label and promotional sales).
• Dispensing pharmacies: prescription dispensing fees, pharmaceutical margins, ancillary healthcare services and repeat visits.
• Cross-selling and loyalty: point programs and store networks increase basket size and frequency.
• Store expansion & format mix: large drugstores for destination shopping plus smaller convenience formats for local repeat customers.
• Operational scale: purchasing leverage and private-label penetration to improve gross margins.

• Store openings: January 2025 expansion of multiple dispensing pharmacies - a major contributor to the 119% YoY sales jump across all stores that month.
• Sales growth: 13.8% rise in net sales for the nine months through Feb 20, 2025 reflects both same-store sales improvements and network expansion.
• Profitability improvement: 68.6% increase in profit attributable to owners over the prior year-driven by operational leverage, pharmacy mix, and cost control.
• Capital markets actions: 3-for-1 share split (Nov 2023) to improve stock liquidity; market cap reached ¥357.66 billion by Dec 12, 2025.

Kusuri No Aoki Holdings Co., Ltd. (3549.T): History

• Public listing: Tokyo Stock Exchange, ticker 3549.
• Leadership: President Hironori Aoki and Vice President Takanori Aoki (brothers).
• Family ownership: A substantial portion of shares is held by the Aoki family; management remains family-centered.
• Share split: 3-for-1 share split executed in November 2023 to improve liquidity and broaden retail investor access.
• Significant institutional interest: As of July 2024, Oasis Management held a 9.7% stake, ranking it the third-largest shareholder.
• Governance dispute: Oasis Management filed a lawsuit in July 2024 raising concerns over governance, specifically the issuance of stock options to the Aoki brothers.

• Shareholder mix: Individual and institutional investors together with concentrated family holdings.
• Proxy and governance focus: Recent activism centers on board practices, related-party compensation and transparency of equity incentives.

Kusuri No Aoki Holdings Co., Ltd. (3549.T): Ownership Structure

• Mission and values: provide a wide product range to meet diverse customer needs; contribute to community health and well‑being; maintain transparency and strong corporate governance; adapt to market changes to ensure sustainable growth.
• Strategic priorities: roll out new stores in under‑served catchments, optimize logistics and category mix, expand private‑brand offerings, and leverage digital channels for customer engagement.

• Annual revenue: ~¥330-380 billion (FY reference year reported by company disclosure)
• Operating income: low‑double digit billion yen range, reflecting high‑volume retail margins and scale benefits
• Net income: single‑to‑low‑double digit billion yen range after taxes and non‑operating items
• Store network: approximately 900-1,100 stores nationwide, expanded through organic openings and selective M&A
• Employees: several thousand employees including store staff and corporate personnel

• Retail sales of pharmaceuticals (prescription and OTC), over‑the‑counter medicines and health supplements.
• Cosmetics and beauty products-high margin categories with targeted promotions and private labels.
• Daily consumables and household goods-staples that drive footfall and repeat visits.
• Services and pharmacy operations-dispensing fees, consultations and health services in store.
• Optimization levers: SKU rationalization, private brand penetration, store format optimization, and omni‑channel sales to raise basket value and improve margins.

• Founder/large shareholders provide stability and long‑term orientation for store expansion and capital allocation.
• Institutional ownership pressures drive emphasis on profit margins, ROE improvement and transparent disclosures.
• Free cash flow allocation typically balances store investment, debt management and returns to shareholders (dividends/share buybacks guided by board policy).

Kusuri No Aoki Holdings Co., Ltd. (3549.T): Mission and Values

• Patient-first pharmacy services: accessible dispensing pharmacies and pharmacist consultations.
• Value retailing: affordable OTC medicines, cosmetics, food, and daily goods alongside pharmaceuticals.
• Community health promotion: vaccination support, health checks, and regional outreach.
• Employee development: continuous training to maintain service quality and regulatory compliance.

• Store network model: combination of directly operated stores and franchised/outlet formats to accelerate geographic coverage and local penetration.
• Product sourcing: procurement from national pharmaceutical wholesalers, direct contracts with drugmakers, and consumer goods suppliers to ensure a broad, quality assortment.
• Centralized management: headquarters oversees merchandising standards, pricing strategies, compliance, and unified procurement to leverage scale.
• Data-driven operations: POS and pharmacy systems feed into analytics platforms that monitor sales performance, customer preferences, prescription trends, and inventory turnover to optimize assortment and reduce stockouts.
• Staff training and development: regular pharmacist licensing support, sales/customer-service training, and standardized operational procedures to raise service consistency.
• Strategic expansion planning: site-selection analytics and market studies guide new store openings and conversion of existing locations to enhance market share.

• Prescription dispensing: steady-margin, recurring revenue driven by aging demographics and chronic medication needs.
• OTC medicines and health goods: higher-margin, high-turnover items that increase basket size per visit.
• Daily commodities and cosmetics: non-pharma categories that drive foot traffic and cross-buying.
• In-store services: pharmacist consultations, health checks, and ancillary services contributing modest service revenue and customer loyalty.

• Merchandising optimization: mix adjustments to prioritize high-margin categories like cosmetics and private-label items.
• Category expansion: in-store food and daily living segments to increase visit frequency and average spend.
• Pharmacy services integration: stronger linkage between prescription customers and retail purchase conversion.
• IT and analytics investments: forecasting and replenishment systems to lower working capital and improve stock availability.
• Store network strategy: targeted openings in suburban and regional markets underserved by competitors to capture aging-population demand.

• Expansion capex: ongoing investment in new stores and remodeling existing outlets to modernize layouts and expand pharmacy space.
• Digital initiatives: e-receipts, loyalty programs, and pharmacy appointment systems to deepen customer engagement and collect behavioral data.
• Training and compliance spend: investment in pharmacist development and regulatory compliance to maintain service standards and license adherence.
• M&A and partnerships: selective acquisitions and alliances to accelerate footprint growth and add specialty services.

Kusuri No Aoki Holdings Co., Ltd. (3549.T): How It Works

• Core retail footprint: company-operated drugstores with attached pharmacies handling prescription dispensing and OTC sales.
• Merchandise breadth: pharmaceuticals, cosmetics, health supplements, daily goods, food (processed & fresh), baby products, household items, clothing basics and pet food.
• Promotions & loyalty: store-level campaigns, point-card/loyalty schemes and seasonal promotions (e.g., winter health, summer skincare) to increase basket value and frequency.
• Omnichannel elements: in-store pickup, limited e-commerce and digital coupons to support convenience-led purchasing.

• Pharmaceutical products: prescription dispensing fees and over-the-counter (OTC) drug sales-the pharmacy function provides stable foot traffic and higher-margin counseling services.
• Cosmetics and personal care: shampoos, skincare, makeup and beauty supplements-seasonal demand and brand promotions lift average selling prices.
• Health supplements and first aid: vitamins, dietary supplements and basic medical supplies, often sold with cross-promotions.
• Daily goods and household items: detergents, cleaning supplies, kitchen consumables-high-turn items with competitive pricing.
• Processed & fresh food: ready-to-eat meals, snacks, refrigerated items-targets convenience shoppers and increases store visit frequency.
• Baby products and clothing basics: diapering, formula, infant toiletry, and low-price apparel items that extend customer lifetime value.
• Pet foods and specialty items: niche categories that diversify revenue and capture specialty spend.

• Promotional windows: sales spikes during campaigns (e.g., point-multiplier weeks) can lift monthly sales by double-digits for promoted categories.
• Seasonality: cold/flu season increases OTC and supplement demand; summer drives skincare and sun-care products.
• Margin management: private-label and own-brand items improve gross margins versus national brands.
• Inventory & assortment: category-specific shelf space and rapid replenishment support high turnover in consumables and food categories.
• Pharmacy services: prescription volume and dispensing fees provide recurring revenue and steady customer visits.

• Expand fresh/processed food assortments to capture convenience-oriented shoppers and increase weekday basket sizes.
• Grow private-label ranges in supplements, daily goods and baby products to lift margins.
• Enhance loyalty and digital coupons to increase repeat purchase rates and enable targeted promotions.
• Broaden specialty categories (pet, organic foods) to attract niche customer segments and diversify income streams.

Kusuri No Aoki Holdings Co., Ltd. (3549.T): How It Makes Money

• Retail drugstores: over-the-counter medicines, cosmetics, daily consumables, nutritional supplements and private-label goods.
• Dispensing pharmacies: prescription fulfilment, reimbursement-driven margins, and fee-for-service pharmaceutical care.
• Services & other: in-store clinics/health consultations, loyalty programs, logistics/wholesale to smaller outlets, and seasonal promotions.

• Profit drivers: same-store sales uplift, higher prescription volumes, margin expansion from private-label products, and economies of scale from new store rollouts.
• Operational levers: inventory optimization, centralized procurement, pharmacy workflow efficiency, and digital customer engagement.
• Investor-focused actions: governance enhancements and efficiency programs intended to improve shareholder value.